S32 (formerly Section 32) is a California-based venture fund founded by

Google Ventures GV Management Company, L.L.C. (file no. 4726690) is a venture capital investment arm of Alphabet Inc., founded by Bill Maris, that provides seed, venture, and growth stage funding to technology companies. Founded as Google Ventures in 2010, th ...

founder, Bill Maris. S32 funds technology companies at all stages and has over $2 billion under management.

History

S32 was founded by the

founder, Bill Maris. Bill Maris' background is in technology and neuroscience, and he retired from Google Ventures (later GV) after he declared "mission accomplished." He founded S32 to invest in frontier technology. The fund aimed to raise $100 million however, citing a strong interest, the first fund raise was $160 million, and the firm now has over $2 billion under management. In December 2017, Michael Pellini, the former CEO and standing Chairman of

Foundation Medicine Foundation Medicine, Inc. is an American company based in Cambridge, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and ...

joined S32 as a Managing Partner. In early 2019, Section 32 announced that it had raised nearly $200M for a second fund. In November 2019, Steve Kafka, joined Section 32 as a Managing Partner. He served as both founding CEO and Executive Chairman of Thrive Earlier Detection, and President and Chief Operating Officer at Foundation Medicine. In 2020, S32 announced it was raising $350M for its third fund. In March 2021, Andy Harrison joined S32 as a Managing Partner. He previously held executive leadership roles at

Alphabet An alphabet is a standard set of letter (alphabet), letters written to represent particular sounds in a spoken language. Specifically, letters largely correspond to phonemes as the smallest sound segments that can distinguish one word from a ...

, including

Verily Life Sciences Verily Life Sciences LLC, also known as Verily (formerly Google Life Sciences), is Alphabet Inc.'s research organization devoted to the study of life sciences. The organization was formerly a division of Google X, until August 10, 2015, when Se ...

(previously Google Life Sciences) and X (previously GoogleX). S32 has notably invested in Coinbase, Crowdstrike, Thrive, Vir, Relay, and Cohere. In November 2021, S32 announced that it raised its fourth fund, Fund 4, from new and existing institutional investors spanning philanthropic, nonprofit and educational organizations, and foundations. The fund was more than double the size of its previous fund and invested in several companies, including quantum and AI application company, SandboxAQ, which spun out of Google in 2022, and synthetic data startup, Gretel Labs. In 2023, S32 raised a $525M Fund 5 to invest in software-driven businesses in tech and healthcare that improve the human condition and named Andy Harrison as CEO of the firm. In February 2024, S32 announced the appointment of Andy Conrad as a General Partner. Conrad, known for his leadership in technology and advanced data science, previously founded and served as the CEO and Executive Chairman of Verily Life Sciences at Alphabet (Google).

References

{{reflist, 2

External links

Official website
Venture capital firms of the United States